The Ministry of health approved the recommendations for the rehabilitation of patients after COVID-19

The Ministry of health has developed and submitted to the regions temporary methodical recommendations on rehabilitation at COVID-19. The document takes into account the peculiarities of rehabilitation in the provision of specialized medical care for patients with novel coronavirus infection, the routing of patients with COVID-19 on the stages of rehabilitation, particularly rehabilitation of children, as well as measures to improve and restore the health employees of health organizations providing care to patients with COVID-19. Special attention is paid to the rehabilitation of patients with cardiovascular disease, according to the website of the Ministry.

According to the provisional recommendations, the referral of patients to medical organizations recommended by means of advanced remote consultation to determine the phase of medical rehabilitation.

Feature of patients with COVID-19 is the necessity of isolation for 14 days after discharge from the rehabilitation stage of specialized or hospital care. It is the optimum time for carrying out activities of medical rehabilitation remotely at home using telemedicine technologies.

For further rehabilitation upon completion of the period post-infection isolation of patients may be sent to the medical organization, including Spa, on the basis of regional road maps and routing

Guidelines intended for physicians of medical institutions infectious profile, as well as doctors offices intensive care the infectious diseases hospital and primary care physicians.

Leave a Reply

Your email address will not be published. Required fields are marked *


Pfizer and Hikma will manufacture ramdevpir

British Hikma announced the start of production of ramdevpir of Gilead, which is currently used for the treatment of patients with COVID-19. A similar agreement for the production of antiretroviral drug Gilead has entered into with Pfizer, writes Reuters. Ramdevpir is one of two drugs that have confirmed efficacy in the treatment of coronavirus infection […]

RNC Pharma: the Russian pharmaceutical manufacturers set an absolute record

The total volume of pharmaceutical production in January-June 2020 reached 232 billion rubles, rate of growth compared to the same period 2019 to 24%, according to the RNC Pharma. Natural dynamics are somewhat more modest: 18.3% packages just for the first half of the domestic companies shipped 2.45 billion packings of medicines. The increase in […]